What is the recommended dose of Novolog Mix 70/30 (insulin aspart protamine/insulin aspart)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Novolog Mix 70/30 Dosing

For insulin-naïve patients with type 2 diabetes, start Novolog Mix 70/30 at 10 units or 0.1-0.2 units/kg body weight per day, divided into two equal doses administered twice daily, 30 minutes before breakfast and dinner. 1

Starting Dose Framework

  • The recommended initial dose is 10 units or 0.1-0.2 units/kg body weight per day, split into two equal doses given before breakfast and dinner. 2, 1

  • Patients with type 2 diabetes commonly require ≥1 unit/kg/day or higher once titrated to goal, which is substantially higher than type 1 diabetes requirements. 1

  • For patients with a history of hypoglycemia, use lower starting doses (closer to 0.1 units/kg/day or even less) as these patients face substantially higher hypoglycemia risk and require more conservative titration. 1

Timing of Administration

  • Administer Novolog Mix 70/30 within 0-5 minutes before meals (breakfast and dinner for twice-daily dosing). 3, 4

  • Postprandial injection (15-20 minutes after meal onset) may be an acceptable alternative for some elderly patients, though it results in slightly higher postprandial glucose excursions compared to preprandial dosing. 4

Dose Titration Strategy

  • Adjust doses every 2 weeks based on self-monitoring of blood glucose, targeting fasting blood glucose of 90-150 mg/dL. 2, 1

  • If ≥50% of fasting values exceed goal over 2 weeks, increase dose by 2 units. 5, 1

  • If >2 fasting values per week are <80 mg/dL, decrease dose by 2 units. 5, 1

Critical Dosing Thresholds

  • When basal insulin exceeds 0.5 units/kg/day and glycemic goals are not met, consider combination injectable therapy or regimen intensification rather than continuing to escalate premixed insulin alone. 1, 3

  • If prandial insulin component is >10 units per dose, consider decreasing dose by 50% and adding a non-insulin agent (such as GLP-1 receptor agonist or SGLT-2 inhibitor) to reduce hypoglycemia risk. 5

Medication Management During Initiation

  • Maintain metformin when starting or intensifying Novolog Mix 70/30. 2, 1, 3

  • Discontinue sulfonylureas and DPP-4 inhibitors to avoid unnecessarily complex regimens and reduce hypoglycemia risk. 2, 1, 3

Common Pitfalls to Avoid

  • Do not use premixed insulin in patients with unpredictable eating patterns or those requiring more precise insulin dosing, as the fixed 70/30 ratio limits flexibility. 1

  • Do not continue escalating Novolog Mix 70/30 indefinitely if HbA1c remains above target—this represents therapeutic inertia and increases hypoglycemia risk without proportional benefit. 1

  • Avoid using rapid-acting insulin at bedtime in older adults. 5

  • For premeal glucose >250 mg/dL, consider adding 2 units of rapid-acting insulin as a simplified sliding scale; for >350 mg/dL, give 4 units. 5

Special Population Considerations

  • In older adults (≥65 years), use more conservative glycemic goals (90-150 mg/dL fasting) and lower starting doses to minimize hypoglycemia risk. 5, 1

  • For older adults on premixed insulin who need simplification, use 70% of the total daily dose as basal insulin only in the morning and discontinue the prandial component. 5

References

Guideline

Insulin Dosing Guidelines for Novolin 70/30

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternatives to Humalog Mix 75/25 for Glycemic Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mealtime Insulin Initiation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.